KRAS and non-small cell lung carcinoma: Interestingly, LKB1 loss in KRAS-mutant non-small cell lung cancers (NSCLC) was also associated with epigenetic silencing of STING expression, which promoted cell survival by mediating tolerance of cytoplasmic DNA accumulation [37].